Therapeutic effects of nebulized verapamil on chronic obstructive pulmonary disease: A randomized and double ‐blind clinical trial

ConclusionThe beneficial impact of inhaled verapamil on the diminishing of dyspnea score along with its bronchodilatory effect would make this selective calcium blocker agent a therapeutic option in COPD.

Source: The Clinical Respiratory Journal - January 19, 2020 Category: Respiratory Medicine Authors: Rama Bozorgmehr, Maryam Edalatifard, Enayat Safavi, Besharat Rahimi, Fariba Ghorbani, Hamidreza Abtahi, Shahideh Amini, Guitti Pourdowlat Tags: ORIGINAL ARTICLE Source Type: research